HIV home tests
This article was originally published in The Tan Sheet
Executive Summary
FTC charges Internet marketer David Rothbart, doing business as Medimax, Inc., with falsely representing that his HIV tests accurately detect the AIDS virus. An Orlando, Fla. federal judge issued a temporary restraining order against Rothbart, barring him from marketing or selling the tests and freezing his assets. FTC alleges that, contrary to Rothbart's promotional materials promising his tests are 99% accurate, "nine of ten of Rothbart's HIV tests provided false negative results when tested with HIV-positive blood; the tenth test did not work at all." The commission also takes issue with Rothbart's sale of a "rapid test" that supposedly gives accurate results in 15 minutes; such HIV tests are not approved for U.S. sale, FTC says. In November, Cyberlinx Marketing settled FTC charges the Internet company falsely represented HIV home test kits as accurately detecting the virus (1"The Tan Sheet" Nov. 29, In Brief)
You may also be interested in...
HIV home tests
Alfa Scientific Designs enjoined from advertising, marketing or selling any HIV tests under a stipulated preliminary injunction filed in San Diego federal court Jan. 13. In a complaint for permanent injunction, FTC alleges that since at least October 1998 Alfa Scientific has marketed HIV tests through its Web site, falsely representing their accuracy. The commission also contends Alfa Scientific supplied faulty HIV tests to Medimax, Inc. and its owner, David Rothbart. In December, FTC charged Medimax with falsely representing through the Internet the accuracy of its HIV test kits. Medimax is preliminarily enjoined from marketing the tests (1"The Tan Sheet" Dec. 13, 1999, p. 2)
False HIV home test kits
Cyberlinx Marketing settles FTC charges the Internet company falsely represented HIV home test kits as accurately detecting HIV. Under the stipulated final settlement order, Cyberlinx and its president, Jeffrey Stein, are banned from marketing HIV home test kits and must reimburse the money received from the sale of the kits within 10 days. The order also prohibits the defendants from transferring, disclosing, or selling information regarding any person who paid money to either of them at any time prior to entry of the order in connection with the purchase of any HIV home test kit. In the event Cyberlinx or Stein wish to market or sell any medical device other than HIV home test kits in the future, they are required to post a $500,000 bond
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC